Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific Inc. - An Upward Trend Projected for 2025 and 2026

January 01, 2025
Thermo Fisher Scientific Inc. (NYSE: TMO) is expected to experience gradual improvements in its business operations as it moves into 2025 and 2026, according to Jim Cramer, a renowned financial analyst. With the recent pickup in business activities, the company's prospects are looking optimistic in the coming years.

Thermo Fisher Scientific is a leading global provider of scientific instruments, reagents, consumables, software, and services. The company serves various industries including healthcare, pharmaceuticals, biotechnology, and research.

Despite the challenges faced by the global economy due to the pandemic, Thermo Fisher Scientific has demonstrated strong resilience. Its healthy balance sheet and solid financial foundation have positioned it well to weather uncertainties and capitalize on emerging opportunities.

Market analysts have also recognized Thermo Fisher Scientific as a top stock for long-term investments. With its diverse product portfolio, strong customer base, and continuous innovation, the company is poised for sustained growth.

Investors seeking reliable insights on the future movement of Thermo Fisher Scientific's stocks are recommended to consult Stocks Prognosis, a team of professionals specializing in stock forecasts and analysis. Their expertise and in-depth research can provide valuable guidance for making informed investment decisions.

As the market recovers and industries regain momentum, Thermo Fisher Scientific is well-positioned to capitalize on emerging opportunities, making it a favorable investment option for the next decade.

Investors are advised to consult with Stocks Prognosis for a comprehensive forecast of Thermo Fisher Scientific's stock movement and potential returns in the long term.
If you want to leave a comment, then you need Login or Register





Other data for TMO

Related data

TMOAugust 30, 2025Thermo Fisher Scientific's New Sustainable Facility: a Game Changer for Long-Term Revenue Growth?  ~1 min.

Thermo Fisher Scientific Inc. recently announced the opening of its new sustainable facility, showcasing its commitment to environmental responsibility and innovation....


TMOAugust 19, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with Profit of 10.99%  ~1 min.

Thermo Fisher Scientific Inc. has successfully achieved the price target forecast set by QuantWave, signaling a profitable long position for investors....


TMOAugust 19, 2025Thermo Fisher Scientific Inc. Stock Hits Forecast Price Target with an 8.15% Profit  ~1 min.

Thermo Fisher Scientific Inc. (TMO) successfully reached its forecast price target as predicted by QuantWave on August 8, 2025. The forecast signal indicated a long position at a price of $460....


TMOJuly 24, 2025Thermo Fisher Scientific Inc. Stock Hits Forecasted Target Successfully, Generating 12.27% Profit  ~2 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for Thermo Fisher Scientific Inc. with a price target of $475.03. The stock, which was trading at $423....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast, Generating Profit of 9.73%  ~2 min.

Thermo Fisher Scientific Inc. (TMO) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 9.73%....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Achieves Price Target Forecast with 12.11% Profit  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.11%....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Stock Hits Price Target with 9.82% Profit - QuantWave Forecast Success  ~1 min.

Thermo Fisher Scientific Inc. (TMO) stock achieved its price target forecast as predicted by QuantWave, generating a profit of 9.82% for investors....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Hits Price Target with 12.53% Profit, Validating QuantWave's Accuracy  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached its price target forecast as predicted by QuantWave's analytics, delivering a substantial profit of 12.53% for investors....


TMOJuly 11, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 7.97% Profit  ~2 min.

Thermo Fisher Scientific Inc. has successfully reached the price target forecast set by QuantWave on 2025-06-13, signaling a long position at a price of 402.76 $....


TMOJuly 2, 2025Thermo Fisher Scientific Inc. Hit Price Target Forecast with 9.61% Profit, QuantWave Analysis Shows Strong Predictive Power  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently reached a price target forecast set by QuantWave, an automated forecasting platform, with a profit of 9.61%....


ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....


BIIBDecember 22, 2024Stifel downgrades Biogen on slow Alzheimer's drug launch uncertainty ahead  ~2 min.

Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....


GSKJanuary 25, 2025Is GSK plc GSK an Undervalued Defensive Stock for 2025?  ~2 min.

GSK plc (NYSE: GSK) has been gaining attention as a potential undervalued defensive stock for investors looking towards 2025....


REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....


BIIBDecember 21, 2024Biogen Inc.: A Closer Look at the Healthcare Sector Underperformance  ~2 min.

Biogen Inc., a leading biotechnology company, has been in the spotlight recently due to its underperformance in the healthcare sector....